Exploiting Nanotechnologies and TRPV1 Channels to Investigate the Putative Anandamide Membrane Transporter

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  Ligresti, Alessia ^a,b   de Petrocellis, Luciano ^a,b   de la Ossa, Dolores Hernán Pérez ^c   Aberturas, Rosario ^d   Cristino, Luigia ^a,b   Moriello, Aniello Schiano ^a,b   Finizio, Andrea ^a   Gil, Esther ^c   Torres, Ana Isabel ^c   Molpeceres, Jesús ^d   di Marzo, Vincenzo ^a,b  

^a CNR   (Italy)

^b Endocannabinoid Research Group   (Italy)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; CALCIUM IONOPHORE; NANOPARTICLE; POLYCAPROLACTONE; RECOMBINANT RECEPTOR; VANILLOID RECEPTOR 1; AMIDE; ARACHIDONIC ACID DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CARRIER PROTEIN; DRUG CARRIER; ENDOCANNABINOID; POLYESTER; VANILLOID RECEPTOR;

ARTICLE; BINDING SITE; BIOSENSOR; CALCIUM CELL LEVEL; CELL STRAIN HEK293; CELL TRANSPORT; CONTROLLED STUDY; CYTOSOL; DIGITAL HOLOGRAPHIC QUANTITATIVE PHASE MICROSCOPY; EXTRACELLULAR CALCIUM; FLUORESCENCE MICROSCOPY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INTERNALIZATION; MEMBRANE TRANSPORT; MICROSCOPY; NANOENCAPSULATION; NANOTECHNOLOGY; PARTICLE SIZE; CELL LINE; CHEMISTRY; METABOLISM;

ARACHIDONIC ACIDS; BINDING SITES; CALCIUM CHANNEL BLOCKERS; CELL LINE; DRUG CARRIERS; ENDOCANNABINOIDS; HUMANS; MEMBRANE TRANSPORT PROTEINS; POLYESTERS; POLYUNSATURATED ALKAMIDES; TRPV CATION CHANNELS;

EID: 77956418155     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010239     Document Type: Article

References (45)

1. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, et al. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949.
2. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, et al. (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372: 686-691.
3. Bisogno T, Maurelli S, Melck D, De Petrocellis L, Di Marzo V (1997) Biosynthesis, Uptake, and Degradation of Anandamide and Palmitoylethanolamide in Leukocytes. J Biol Chem 272: 3315-3323.
4. Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A, et al. (1997) Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 277: 1094-1097.
5. Hájos N, Kathuria S, Dinh T, Piomelli D, Freund TF (2004) Endocannabinoid transport tightly controls 2-arachidonoyl glycerol actions in the hippocampus: effects of low temperature and the transport inhibitor AM404. Eur J Neurosci 19: 2991-2996.
6. Ligresti A, Morera E, Van Der Stelt M, Monory K, Lutz B, et al. (2004) Further evidence for the existence of a specific process for the membrane transport of anandamide. Biochem J 380: 265-272.
7. Di Marzo V, Bisogno T, Melck D, Ross R, Brockie H, et al. (1998) Interactions between synthetic vanilloids and the endogenous cannabinoid system. FEBS Lett 436: 449-454.
8. López-Rodríguez ML, Viso A, Ortega-Gutiérrez S, Fowler CJ, Tiger G, et al. (2003) Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors. Eur J Med Chem 38: 403-412.
9. Ortar G, Ligresti A, De Petrocellis L, Morera E, Di Marzo V (2003) Novel selective and metabolically stable inhibitors of anandamide cellular uptake. Biochem Pharmacol 65: 1473-1481.
10. De Lago E, Ligresti A, Ortar G, Morera E, Cabranes A, et al. (2004) In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake. Eur J Pharmacol 484: 249-257.
11. Maione S, Morera E, Marabese I, Ligresti A, Luongo L, et al. (2008) Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: cannabinoid and non-cannabinoid receptor-mediated mechanisms. Br J Pharmacol 155: 775-782.
12. Thors L, Fowler CJ (2006) Is there a temperature-dependent uptake of anandamide into cells? Br J Pharmacol 149: 73-81.
13. Bojesen IN, Hansen HS (2006) Effect of an unstirred layer on the membrane permeability of anandamide. J Lipid Res 47: 561-570.
14. Kaczocha M, Hermann A, Glaser ST, Bojesen IN, Deutsch DG (2006) Anandamide Uptake Is Consistent with Rate-limited Diffusion and Is Regulated by the Degree of Its Hydrolysis by Fatty Acid Amide Hydrolase. J Biol Chem 281: 9066-9075.
15. Hillard CJ, Shi L, Tuniki VR, Falck JR, Campbell WB (2007) Studies of anandamide accumulation inhibitors in cerebellar granule neurons: comparison to inhibition of fatty acid amide hydrolase. J Mol Neurosci 33: 18-24.
16. Hillard CJ, Jarrahian A (2003) Cellular accumulation of anandamide: consensus and controversy. Br J Pharmacol 140: 802-808.
17. Ortega-Gutiérrez S, Hawkins EG, Viso A, López-Rodríguez ML, Cravatt BF (2004) Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake. Biochemistry 43: 8184-90.
18. Fowler CJ, Tiger G, Ligresti A, López-Rodríguez ML, Di Marzo V (2004) Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis-a difficult issue to handle. Eur J Pharmacol 492: 1-11.
19. Jordt S-E, Julius D (2002) Molecular Basis for Species-Specific Sensitivity to ''Hot'' Chili Peppers. Cell 108: 421-430.
20. De Petrocellis L, Bisogno T, Maccarrone M, Davis JB, Finazzi-Agro A, et al. (2001) The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J Biol Chem 276: 12856-12863.
21. De Petrocellis L, Davis JB, Di Marzo V (2001) Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors. FEBS Lett 506: 253-256.
22. Fegley D, Kathuria S, Mercier R, Li C, Goutopoulos A, et al. (2004) Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. Proc Natl Acad Sci USA 101: 8756-8761.
23. Bari M, Battista N, Fezza F, Finazzi-Agrò A, Maccarrone M (2005) Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis. J Biol Chem 280: 12212-12220.
24. Bari M, Oddi S, De Simone C, Spagnolo P, Gasperi V, et al. (2008) Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells. Neuropharmacology 54: 45-50.
25. Kaczocha M, Glaser ST, Deutsch DG (2009) Identification of intracellular carriers for the endocannabinoid anandamide. Proc Natl Acad Sci USA 106: 6375-6380.
26. Oddi S, Fezza F, Pasquariello N, D'Agostino A, Catanzaro G, et al. (2009) Molecular Identification of Albumin and Hsp70 as Cytosolic Anandamide- Binding. Proteins Chem Biol 16: 624-632.
27. Garrett ER, Hunt A (1974) Physicochemical properties, solubility, and protein binding of D9-Tetrahydrocannabinol. J Pharm Sci 63: 1056-1064.
28. Di Marzo V, Goparaju SK, Wang L, Liu J, Bátkai S, et al. (2001) Leptinregulated endocannabinoids are involved in maintaining food intake. Nature 410: 822-825.
29. Vasir JK, Labhasetwar V (2007) Biodegradable nanoparticles for cytosolic delivery of therapeutics. Adv Drug Deliv Rev 59: 718-728.
30. Dausend J, Musyanovych A, Dass M, Walther P, Schrezenmeier H, et al. (2008) Uptake Mechanism of Oppositely Charged Fluorescent Nanoparticles in HeLa Cells. Macromolecular Bioscience 8: 1135-1143.
31. Mailänder V, Landfester K (2009) Interaction of Nanoparticles with Cells. Biomacromolecules 10: 2379-2400.
32. Maccarrone M, Bari M, Lorenzon T, Bisogno T, Di Marzo V, et al. (2000) Anandamide Uptake by Human Endothelial Cells and Its Regulation by Nitric Oxide. J Biol Chem 275: 13484-13492.
33. Thors L, Eriksson J, Fowler CJ (2007) Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase-driven uptake. Br J Pharmacol 152: 744-750.
34. Bojesen IN, Hansen HS (2005) Membrane transport of anandamide through resealed human red blood cell membranes. J Lipid Res 46: 1652-1659.
35. Di Pasquale E, Chahinian H, Sanchez P, Fantini J (2009) The Insertion and Transport of Anandamide in Synthetic Lipid Membranes Are Both Cholesterol- Dependent. PLoS One 4: e4989.
36. Karlsson M, Pa°hlsson C, Fowler CJ (2004) Reversible, temperature-dependent, and AM404-inhibitable adsorption of anandamide to cell culture wells as a confounding factor in release experiments. Eur J Pharm Sci 22: 181-189.
37. Chawla JS, Amiji MM (2002) Biodegradable poly(e-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen. Int J Pharm 249: 127-138.
38. Davda J, Labhasetwar V (2002) Characterization of nanoparticle uptake by endothelial cells. Int J Pharm 233: 51-59.
39. Mann CJ, Yu L, Lo C-M, Kim MK (2005) High-resolution quantitative phasecontrast microscopy by digital holography. Opt Express 13: 8693-8698.
40. Cuche E, Bevilacqua F, Depeursinge C (1999) Digital holography for quantitative phase-contrast imaging. Opt Lett 24: 291-293.
41. Ferraro P, Alferi D, De Nicola S, De Petrocellis L, Finizio A, et al. (2006) Quantitative phase-contrast microscopy by a lateral shear approach to digital holographic image reconstruction. Opt Lett 31: 1405-1407.
42. Mann C, Yu L, Kim M (2006) Movies of cellular and sub-cellular motion by digital holographic microscopy. Biomed Eng Online 5: 21.
43. Miccio L, Grilli S, Finizio A, De Nicola S, De Petrocellis L, et al. (2007) Lipid particle detection by means digital holography and lateral shear interferometry. in ''Novel Optical Instrumentation for Biomedical Applications III'', vol. 6631 of ''SPIE Proceedings'': 66310G. C. D. Depeursinge ed.
44. Jeong K, John T, Nolte DD (2007) Volumetric motility-contrast imaging of tissue response to cytoskeletal anti-cancer drugs. Opt Express 15: 14057-14064.
45. Rappaz B, Barbul A, Hoffmann A, Boss D, Korenstein R, et al. (2009) Spatial analysis of erythrocyte membrane fluctuations by digital holographic microscopy. Blood Cells Mol Dis 42: 228-232.